公开(公告)号：US20190000965A1

公开(公告)日：2019-01-03

申请号：US16109570

申请日：2018-08-22

Applicant: MERIAL, INC.

Inventor： Frederic David ,  Zahia Hannas-Djebbara ,  Herve Poulet ,  Jules Maarten Minke

IPC: A61K39/23

Abstract: The present disclosure encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs are formed by the CPV VP2 protein. Further, the disclosure broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.

公开(公告)号：US20170087244A1

公开(公告)日：2017-03-30

申请号：US15265545

申请日：2016-09-14

Applicant: MERIAL, INC.

Inventor： Frederic David ,  Zahia Hannas-Djebbara ,  Herve Poulet ,  Jules Maarten Minke

IPC: A61K39/23 ,  C07K14/005 ,  C12N7/00 ,  A61K39/135

CPC classification number: A61K39/23 ,  A61K39/12 ,  A61K39/135 ,  A61K2039/5258 ,  A61K2039/545 ,  A61K2039/552 ,  A61K2039/575 ,  A61K2039/70 ,  C07K14/005 ,  C12N7/00 ,  C12N2750/14323 ,  C12N2750/14334 ,  C12N2750/14371 ,  C12N2770/32123 ,  C12N2770/32134

Abstract: The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.

公开(公告)号：US20180243399A1

公开(公告)日：2018-08-30

申请号：US15753324

申请日：2016-08-16

Applicant: MERIAL INC.

Inventor： Herve Poulet ,  Frédéric Reynard

IPC: A61K39/125 ,  C12N7/04

Abstract: The present invention encompasses FCV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FCV antigens. The invention also encompasses recombinant vectors encoding and expressing FCV antigens, epitopes or immunogens which can be used to protect animals against FCV infection.

公开(公告)号：US10080798B2

公开(公告)日：2018-09-25

申请号：US15265545

申请日：2016-09-14

Applicant: MERIAL, INC.

Inventor： Frederic David ,  Zahia Hannas-Djebbara ,  Herve Poulet ,  Jules Maarten Minke

IPC: A61K39/23 ,  C07K14/005 ,  C12N7/00 ,  A61K39/135 ,  A61K39/12 ,  A61K39/00

CPC classification number: A61K39/23 ,  A61K39/12 ,  A61K39/135 ,  A61K2039/525 ,  A61K2039/5258 ,  A61K2039/545 ,  A61K2039/552 ,  A61K2039/575 ,  A61K2039/70 ,  C07K14/005 ,  C12N7/00 ,  C12N2750/14323 ,  C12N2750/14334 ,  C12N2750/14371 ,  C12N2770/32123 ,  C12N2770/32134

Abstract: The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.

公开(公告)号：US20180250382A1

公开(公告)日：2018-09-06

申请号：US15846735

申请日：2016-06-23

Applicant: MERIAL INC.

Inventor： Yu-Wei Chiang ,  David Cureton ,  Herve Poulet

IPC: A61K39/145 ,  A61P31/16 ,  G01N33/569

CPC classification number: A61K39/145 ,  A61K39/12 ,  A61K2039/5252 ,  A61K2039/552 ,  A61K2039/55505 ,  A61K2039/55566 ,  A61K2039/70 ,  A61P31/16 ,  C12N2760/16134 ,  G01N33/56983

Abstract: The present invention relates to canine influenza virus strains, and vaccines and compositions. The present invention also relates to reagents and methods allowing their detection, methods of vaccination as well as methods of producing these reagents and vaccines.